Revolutionary Anti-Inflammatory Peptide from Australian Abalone
The First Abalone Peptide Scientifically Validated for Inflammation Support
Powered by Nature. Proven by Science.
The World’s First Scientifically Validated Abalone Peptide backed by CSIRO.
Preclinically Proven.
Food-Grade.
Patent-Protected.
15 Years of Research.
One Breakthrough Marine Peptide.
Key Highlights of ABAGEN®
79% Reduction in Nitric Oxide (NO)
In in vitro macrophage models, Abagen® showed a significant reduction in nitric oxide levels, a key pro-inflammatory mediator.
50% Reduction in Arthritis Severity
In vivo testing on mice with collagen-induced arthritis (CIA) showed that Abagen® reduced arthritis scores by half.
Interleukin-6 (IL-6) Expression
Abagen® down-regulated IL-6, a cytokine strongly associated with chronic inflammation, autoimmune conditions, and age-related degeneration.
Targets TNF-α and COX-2 Pathways
Abagen® modulates inflammatory gene expression, helping reduce systemic inflammation without immunosuppressive side effects.
Why Abagen®?
Abagen® is the world’s first clinically studied abalone peptide developed over 15 years with Australia’s national science agency, CSIRO.
Shown in in vivo and in vitro studies to reduce inflammatory markers, improve cell viability, and support joint recovery.
Abagen® is food-grade, patent-protected, and derived from premium Australian abalone using advanced nanofiltration technology.
For Doctors & Scientists
Dive into the peer-reviewed science behind Abagen®, including detailed clinical data and its potential applications in treating inflammatory diseases. Whether researching rheumatoid arthritis or exploring novel IL-6 inhibitors, Abagen® provides a promising avenue for investigation and therapeutic development.
Natural Innovation
Sourced from Haliotis rubra, Abagen® delivers powerful anti-inflammatory effects through a natural, protein-enriched peptide. Southern Ocean Biotech harnesses marine biotechnology to advance health solutions.
Be the First to Discover Abagen®
Subscribe for exclusive updates!
Get early access to information about Abagen®